Pharmacological Treatment of H. Pylori Related Peptic Ulcer Disease

Pharmacological Treatment of H. Pylori Related Peptic Ulcer Disease
A desktop/laptop computer is required to access this course
3 CE Credit Hours
$14.95

This course provides an in-depth review of peptic ulcer disease (PUD), focusing on its etiology, symptoms, diagnosis, and treatment. Learn about evidence-based pharmacologic therapies, including antacids, H2 receptor antagonists, proton pump inhibitors, sucralfate, misoprostol, and H. pylori eradication regimens. Additionally, explore nonpharmacologic approaches and key patient education strategies to optimize treatment outcomes. Earn 3 CE Credit Hours with automatic reporting to CEBroker.com.

Description

Details

Peptic ulcer disease (PUD) affects millions worldwide, often due to H. pylori infection or prolonged NSAID use. This course comprehensively reviews the pathophysiology, symptoms, and diagnosis of gastric and duodenal ulcers. It covers pharmacologic and nonpharmacologic treatment approaches, focusing on evidence-based pharmacotherapy.

Participants will gain in-depth knowledge of the mechanisms of action, indications, and potential adverse effects of key medications, including:

  • Antacids
  • H2 receptor antagonists
  • Proton pump inhibitors (PPIs)
  • Sucralfate
  • Misoprostol
  • Antibiotic regimens for H. pylori eradication

Additionally, the course highlights patient education strategies, including lifestyle modifications and medication adherence, to optimize treatment outcomes.


Course Completion Requirements:

To earn 2 CE Credit Hour, participants must:

  • Be registered for this course.
  • Review all course materials.
  • Complete the post-test with a score of 70% or higher.
  • Submit the course evaluation survey.

Note: Some courses may also include participation in discussion boards, practice exercises, or additional activities.


Important Disclosures:

  • Conflict of Interest: The planners, authors, and presenters have no conflicts of interest or financial relationships with commercial entities related to this CE activity.
  • Commercial Support: No commercial company has sponsored this course.
  • Non-Endorsement: Approval of this CE activity does not imply endorsement of any product, service, or company.
  • Off-Label Product Use: This course does not include unapproved uses of FDA-regulated products.
Illustration of nonpharmacologic treatments for peptic ulcer disease, including healthy diet, stress reduction, smoking cessation, and lifestyle changes, depicted in a modern, flat medical illustration style.

Key Course Benefits:

CEBroker 24hr Bagde
  • Learn current guidelines for PUD treatment
  • Understand pharmacologic and nonpharmacologic management options
  • Gain practical strategies for patient education and medication adherence
  • Earn 3 CE Credit Hours with automatic reporting to CEBroker.com

Approvals and Accreditation:

  • National Healthcare Institute (NHI) is an approved provider of continuing nursing education by:

    • Florida Board of Nursing
    • District of Columbia Board of Nursing

    This course meets the standards of the American Nurses Credentialing Center’s Commission on Accreditation, ensuring high-quality continuing education.

>